TABLE 1

Pulmonary exacerbation frequency in adult cystic fibrosis patients with high or low plasma levels of calprotectin

	Calprotectin <150 ng·L⁻¹	Calprotectin ≥150 ng·L⁻¹	p-value
Subjects	33	16
Pulmonary exacerbations
1-year prior	0.45±0.97	2.0±2.3	0.019
1-year post	0.42±0.93	2.5±2.47	0.0048

Data are presented as n or mean±sd, unless otherwise stated.